Linda0623

Hi Logan, I am an AABB perioperative assessor (and laboratory manager )that works at a facility in Boston MA that uses cell salvage on over 3,000 cases annually. We have 11 machines, and although we are not (yet) accredited by AABB, with the work we have done with our program, we are hoping to be accredited for periop by our next BB inspection. I got involved in this because our SVP for surgical services asked me, as the resident AABB SME, LOL, to evaluate effectiveness of cell salvage at our facility. She wanted us to adhere to the AABB standards and thought I was their best cand

Hi All, Does anyone out there have a critical value for CPK (Creatine Phosphokinase)????? If so, what is your cut off value? We do not currently have a critical value for this test, but our medical director was asked by a specialist to consider a cut off of 2000mg/dL where he considers that a very high abnormal for patients he typically sees. However, we do orthopedic surgery here and do not think this is a good place to start, if we add this at all. Any thoughts would be very appreciated!!!!! Linda

Absolutely fantastic news and well deserved! Congratulations!!!!

Marking my calendar as we speak! It will be awesome to see and hear you lecture again Malcolm! As Kate says, Providence is "just down the road a piece" from Boston

Hi All, Though i don't have experience with this specific product, it sounds as if it could fall under the same types of products as platelet gel, bone marrow aspirate concentrate etc. Maybe AABB periop folks or the hemovigilance folks would have some ideas?

Good Morning- I have attended the UBS course, and have found it extremely valuable. I am a blood bank manager and we do NOT have either a TSO position in our hospital, nor have we a formal blood management program. I used the knowledge I gained to empower transfusion committee to push for several blood management strategies to be implemented, and our organization is realizing great benefits since I attended the class in Sep 2014. We have reduced transfusions by over 50% and are still realizing continued reductions 14 months later. We are predominantly orthopedics based, and aft

I believe it does, because we actually had the FDA approve our process with the Blood Supplier doing the irradiation before they started performing the task for us :-)----because they do not enter the product into their inventory as a distributable product, only as modified, we retain the responsibility of tracking through final disposition.

I will be there----Hopefully achieving my goal to become an AABB assessor for both Blood Bank and Periop activities! :-)----I got accepted into training, the rest is up to me, lol!

In our practice, we ensure BOTH facilities information are on the final label. We collect blood, but do not irradiate on site. So if I need our blood supplier to irradiate a unit that we have collected, our LIS allows us to make the component and enter the modifying facility's ICCBBA/FDA information in the bottom right quadrant of the label, and it is linked in the audit trail of the modification of the product. It also adds the statement "Further Processing By:" preceding the FDA license/registration information. Because we are the collecting facility to which the DIN and collection /FDA regi

I agree with all of the above, and I will raise one other consideration: I manage a small but vital blood donor center as well as the transfusion medicine service. Therefore, we are also FDA registered. AABB with their advisory groups, etc. are like a translator for the CFR and blood guidances' "legal-ese" that we have to maintain. I will always advocate us to keep AABB accreditation as long as I am involved with donor collections and also with perioperative collections (cell salvage, PRP, BMAC etc.)---I oversee their (surgical services) quality program as well as mine. If you are going to mai

Thanks to all for responding so far! This will be very helpful to present to nursing. Best, Linda

Question series for you all on Issuing and Bedside Readback information, particularly for patients with antibodies: When issuing to a runner, does the tech issuing blood do a readback of patient and product demographics, blood type, DIN, etc. when they pick up blood?For Patients with antibodies, ( if you issue to runners vs. through pneumatic tube) do you include patient antibodies on the crossmatch tag/label, and if yes, is it part of a readback between the tech issuing and the runner?If you do not perform a readback at issue with the runner or you use the pneumatic tube, is the antibody st

We have always issued individual units in plastic biohazard bags---multiples for the OR go in coolers......we've never been cited by the JC for it, but we are entering our window for the next inspection so I too, would be interested in knowing what regulation is cited.

Hi Bev, I still have the factors in Blood Bank, although recently our Transfusion Committee chairmen, when achieving the goal of getting approval for bringing FEIBA in-house, has explicitly stipulated that he wants Pharmacy to handle it...... its an antidote not a blood product....etc.....and so the turf wars begin! (Our pharmacy prefers us to handle them). At any rate, I have a consignment contract through a company called Bio- Care. I believe Tufts and Children's use it as well. I stock our most frequently requested products, Humate-p, advate, novoseven, to name a few, and I can add FEIB